Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rifaximin to Modify the Disease Course in Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03719729
Recruitment Status : Unknown
Verified August 2018 by New York Medical College.
Recruitment status was:  Recruiting
First Posted : October 25, 2018
Last Update Posted : March 14, 2019
Sponsor:
Information provided by (Responsible Party):
New York Medical College

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : February 22, 2020
Estimated Study Completion Date : July 22, 2020